繁 简 About Us Company Profile Corporate Structure Milestones Core Business R&D and Production Base Zhuhai R&D and Production Base Kunming R&D and Production Base Global Sales Network Chinese Medicine Development Chinese Medicine R&D Chinese Medicinal Materials Decoction Slices Biomedical Technology and Products Tianda Products Pipeline Quality Healthcare Services Investor Relations Corporate Information Corporate Governance Announcements & Circulars Financial Statements Shares and Details Investor Calendar Investor Enquiries Email Alerts Notices (Replacement of Lost Share Certificates) Dissemination of Corporate Communications Sustainability Our Sustainable Development ESG Report Careers Wort At Tianda Recruitment Vacancies Internship Programmes Trainee Programmes Media Centre Press Releases Media Coverage Contact Us 2017 Select Year 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 24.11.2017 天大藥業(00455.HK)中期溢利減少77%至263.6萬港元(Chinese version only) (Multi Sources) 23.11.2017 BRIEF-Tianda Pharmaceuticals posts HY profit attributable of HK$2.6 million (Multi Sources) 21.11.2017 Tianda Pharma (00455) tips decline in interim net profit (Multi Sources) 13.11.2017 天大藥業拓電商 (Chinese version only) (Ming Pao) 20.07.2017 天大藥業收購仁宏醫藥 進一步擴展中醫領域(Chinese version only) (Moment Magazine) 03.07.2017 《公司業績》天大藥業(00455.HK)全年純利1,244萬 末期息0.57仙(Chinese version only) (Multi Sources) 13.06.2017 天大藥業(00455)擬514.1萬元收購珠海仁宏醫藥100%股權(Chinese version only) (Multi Sources) 24.04.2017 天大藥業凝聚反彈條件(Chinese Version Only) (Takungpao.com) 07.04.2017 天大藥業投資有回報(Chinese Version Only) (Metro Daily) 07.02.2017 中醫藥行業迎來爆發增長(Chinese Version Only) (Finbanana)
